Boston Scientific (BSX) Competitors

Boston Scientific (NYSE:BSX) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, community ranking, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

Does the MarketBeat Community favor BSX or ABT?

Boston Scientific received 110 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.97% of users gave Abbott Laboratories an outperform vote while only 69.70% of users gave Boston Scientific an outperform vote.

Company	Underperform	Outperform
Boston Scientific	Outperform Votes 1056 69.70%	Underperform Votes 459 30.30%
Abbott Laboratories	Outperform Votes 946 69.97%	Underperform Votes 406 30.03%

Which has more volatility & risk, BSX or ABT?

Boston Scientific has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500.

Which has preferable earnings & valuation, BSX or ABT?

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Abbott Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$16.75B	8.89	$1.85B	$1.25	80.53
Abbott Laboratories	$41.95B	5.22	$13.40B	$7.65	16.49

Does the media prefer BSX or ABT?

In the previous week, Abbott Laboratories had 27 more articles in the media than Boston Scientific. MarketBeat recorded 64 mentions for Abbott Laboratories and 37 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.56 beat Abbott Laboratories' score of 1.49 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	35 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Abbott Laboratories	61 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is BSX or ABT more profitable?

Abbott Laboratories has a net margin of 31.95% compared to Boston Scientific's net margin of 11.07%. Abbott Laboratories' return on equity of 20.74% beat Boston Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	11.07%	17.80%	9.85%
Abbott Laboratories	31.95%	20.74%	11.19%

Do insiders and institutionals have more ownership in BSX or ABT?

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.5% of Boston Scientific shares are owned by insiders. Comparatively, 1.1% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Do analysts recommend BSX or ABT?

Boston Scientific presently has a consensus target price of $108.91, indicating a potential upside of 8.20%. Abbott Laboratories has a consensus target price of $137.94, indicating a potential upside of 9.33%. Given Abbott Laboratories' higher probable upside, analysts plainly believe Abbott Laboratories is more favorable than Boston Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	0 Sell rating(s)	1 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	3.00
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.84

Summary

Abbott Laboratories beats Boston Scientific on 10 of the 18 factors compared between the two stocks.